News

Soleno Therapeutics Presents Clinical Data on DCCR at 2018 Foundation for Prader-Willi Research Annual Conference

October 08, 2018

Oral presentation on DCCR’s mechanism of action in treating hyperphagia Poster presentation on DCCR’...

Read More

Soleno Therapeutics Presents Clinical Data on DCCR at Late-Breaking Session of European Society for Paediatric Endocrinology

October 01, 2018

Pharmacokinetic data supports once-daily dosing Long-term use of DCCR not associated with compromised glycemic control ...

Read More

Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease

September 19, 2018

REDWOOD CITY, Calif. , Sept. 19, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical ...

Read More
Soleno – Home